Ljubljana, Slovenia

Petra Kralj

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petra Kralj. Retrieved from https://idiyas.com/inventor/petra-kralj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petra Kralj: Innovator in Pharmaceutical Composition

Introduction

Petra Kralj is a notable inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address critical health issues.

Latest Patents

Petra holds a patent for a process related to the preparation of a pharmaceutical composition comprising a poorly soluble pharmaceutically active ingredient. This innovative composition is designed to create a dosage form that effectively treats hypercholesterolemia, a condition characterized by high cholesterol levels.

Career Highlights

Petra Kralj is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. Her work focuses on enhancing the solubility of active ingredients, which is crucial for the efficacy of medications.

Collaborations

Throughout her career, Petra has collaborated with talented professionals, including Bostjan Markun and Sandra Berglez. These partnerships have contributed to her success and the advancement of pharmaceutical innovations.

Conclusion

Petra Kralj's work exemplifies the importance of innovation in the pharmaceutical sector. Her contributions are paving the way for more effective treatments for conditions like hypercholesterolemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…